However, the expression of TET2 was significantly downregulated relative to AML due to promoter hypermethylation, whereas DNMT1, DNMT3A, and DNMT3B were slightly upregulated by either demethylation or gained chromatin interactions. Here, TET2 is linked to acute myeloid leukemia.